Products

First Pass

Articles from leading publications summarized and analyzed - so you get to what matters quicker.

firstpass.news Entertainment & Media / News & Media

AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
Unknown
No monthly subscription pricing
Creators
Saahil Chamdia
No social account linked
Launched
4mo ago
2026-07-15 · Est.

Traffic

Last 12 months
Monthly visitsData through Oct 2026
Events1 marketing move

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on Product HuntLaunch

    News, Your Way

    Jul 15 · 4mo agoLaunch page

Traffic sources

Oct 2026

Traffic breakdown

Channels

  • Direct32%
  • Organic Search28%
  • Referrals13%
  • Display Ads7%
  • Other20%

Countries

  • France85%
  • United Kingdom15%

Search

Domain authority —Domain registered 2026-03-12

KeywordMonthly volume
indystar1,720
al jazeera’s “kenya confirms first ebola case as man dies in nairobi after drc return”430
estados unidos y las desapariciones en iran120
wall street journal free alternatives100

Traffic data: Vaneform

Pricing

Pricing page not identified yet, or no public pricing listed.

Pages & changes

Tracked since 2026-07-15

Key pages

Weekly snapshots
firstpass.news/ Snapshot 2026-11-03

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much website traffic does First Pass get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is First Pass and what platforms does it support?
First Pass is catalogued under News & Media: Articles from leading publications summarized and analyzed - so you get to what matters quicker.. Supported platforms: Web.

Related products in this category

Entertainment & Media / News & Media

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.